Otsuka 

$20.77
7
+$2.12+11.34% Monday 13:30

Statistics

Day High
20.77
Day Low
20.77
52W High
23.04
52W Low
19
Volume
1,000
Avg. Volume
-
Mkt Cap
7.89B
P/E Ratio
26.69
Dividend Yield
1.53%
Dividend
0.32

Upcoming

Dividends

1.53%Dividend Yield
Mar 26
$0.29
Sep 25
$0.31
Mar 25
$0.03
Mar 25
$0.48
Mar 24
$0.48
10Y Growth
5.62%
5Y Growth
10.56%
3Y Growth
12.07%
1Y Growth
5.56%

Earnings

3AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.19
0.25
0.3
0.35
Expected EPS
0.239393048139
Actual EPS
N/A

Financials

4.81%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
14.61BRevenue
702.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OSUKF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap328.49B
Roche operates in similar pharmaceutical and diagnostics segments, competing directly in the development of innovative drugs and health solutions.
Pfizer
PFE
Mkt Cap149.77B
Pfizer competes in the pharmaceutical sector, offering a wide range of products that overlap with Otsuka's portfolio, including mental health medications.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson's broad healthcare portfolio, including pharmaceuticals and medical devices, positions it as a competitor across several of Otsuka's business areas.
Novartis
NVS
Mkt Cap279.67B
Novartis competes in pharmaceuticals and healthcare, offering products in areas like neurology and psychiatry, directly competing with Otsuka's offerings.
Merck
MRK
Mkt Cap277.02B
Merck operates in the pharmaceutical industry, competing with Otsuka in areas such as healthcare solutions and drug development.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, with its strong presence in the pharmaceuticals sector, competes in areas of mutual interest like neuroscience and oncology.
Takeda Pharmaceutical
TAK
Mkt Cap52.51B
Takeda Pharmaceutical Company has a significant overlap with Otsuka in the pharmaceutical sector, especially in Japan, competing in similar therapeutic areas.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes with Otsuka in the pharmaceutical and healthcare sectors, including areas like mental health.
Sanofi
SNY
Mkt Cap110.4B
Sanofi operates globally in the pharmaceutical sector, competing with Otsuka in various therapeutic areas, including mental health and neurology.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca is a global competitor in the pharmaceutical industry, with a product range that competes with Otsuka's, especially in the oncology and neurology segments.

About

Otsuka Corporation, together with its subsidiaries, provides information services in Japan. It operates through System Integration Business, and Service and Support Business segments. The System Integration Business segment offers computers, copiers, and communication equipment and software, as well as consigned software development and other activities. This segment also provides system services, such as consulting, system design and development, transport and installation work, and network construction services. The Service and Support Business segment is involved in distributing supplies, hardware and software maintenance, telephone support, and outsourcing to support the installed systems and their business operations; and offers educational support services. The company provides management systems and collaborative software, such as ERP packages and groupware to cover a range of specialized fields, including CAD and web technologies; and software, hardware, intranet, and security products for the construction and expansion of computer networks, as well as intermediary services between manufacturers and system integrators. It also engages in the provision of emergency computer rescue services for corporate and individual clients; and coordination of multi-vendor efforts consisting of pick-up, repair, and return of computers. In addition, the company offers 24/7 network support and services for the planning, design, construction, and operation of corporate information systems; and out-sources system engineers. Otsuka Corporation was incorporated in 1961 and is headquartered in Chiyoda, Japan.
Show more...
CEO
Mr. Yuji Otsuka
Employees
9680
Country
Japan
ISIN
JP3188200004

Listings

0 Comments

Share your thoughts

FAQ

What is Otsuka stock price today?
The current price of OSUKF is $20.77 USD — it has increased by +11.34% in the past 24 hours. Watch Otsuka stock price performance more closely on the chart.
What is Otsuka stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Otsuka stocks are traded under the ticker OSUKF.
What is Otsuka market cap?
Today Otsuka has the market capitalization of 7.89B
When is the next Otsuka earnings date?
Otsuka is going to release the next earnings report on August 03, 2026.
What were Otsuka earnings last quarter?
OSUKF earnings for the last quarter are 0.28 USD per share, whereas the estimation was 0.25 USD resulting in a +9.6% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Otsuka revenue for the last year?
Otsuka revenue for the last year amounts to 14.61B USD.
What is Otsuka net income for the last year?
OSUKF net income for the last year is 702.99M USD.
Does Otsuka pay dividends?
Yes, OSUKF dividends are paid semi-annual. The last dividend per share was 0.29 USD. As of today, Dividend Yield (FWD)% is 1.53%.
How many employees does Otsuka have?
As of May 06, 2026, the company has 9,680 employees.
In which sector is Otsuka located?
Otsuka operates in the Technology sector.
When did Otsuka complete a stock split?
The last stock split for Otsuka was on March 28, 2024 with a ratio of 2:1.
Where is Otsuka headquartered?
Otsuka is headquartered in Tokyo, Japan.